These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12082199)

  • 61. Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial.
    Blankenship JC; Hellkamp AS; Aguirre FV; Demko SL; Topol EJ; Califf RM
    Am J Cardiol; 1998 Jan; 81(1):36-40. PubMed ID: 9462603
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts.
    Barsness GW; Buller C; Ohman EM; Schechter E; Pucillo A; Taylor MA; Miller MJ; Reiner JS; Churchill D; Chandler AB; Gonzalez M; Smith J; Tommaso C; Berdan LG; Wildermann NM; Hasdai D; Holmes DR
    Am Heart J; 2000 May; 139(5):824-9. PubMed ID: 10783216
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Free wall rupture following rescue angioplasty and intravenous abciximab for failed thrombolysis.
    Balachandran KP; Oldroyd KG
    Scott Med J; 2001 Jun; 46(3):87-8. PubMed ID: 11501328
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Acute profound thrombocytopenia associated with the use of abciximab: case report].
    Álvarez-Camarena B; Frutos-Rangel E; Rico-Curiel E; García-y Otero JM; Frutos-Rodríguez E
    Arch Cardiol Mex; 2011; 81(4):317-21. PubMed ID: 22188887
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty. RAPPORT investigators. ReoPro And Primary PTCA Organization and Randomized Trial.
    Brener SJ; Barr LA; Burchenal JE; Wolski KE; Effron MB; Topol EJ
    Am J Cardiol; 1999 Sep; 84(6):728-30, A8. PubMed ID: 10498145
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Readministration of abciximab: interim report of the ReoPro readministration registry.
    Tcheng JE; Kereiakes DJ; Braden GA; Jordan RE; Mascelli MA; Langrall MA; Effron MB
    Am Heart J; 1999 Jul; 138(1 Pt 2):S33-8. PubMed ID: 10385789
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Abciximab-induced acute profound thrombocytopenia postpercutaneous coronary intervention.
    Golden T; Ghazala S; Wadeea R; Junna S
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28710245
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Management of a spontaneous renal capsule hematoma following cardiac catheterization involving use of a platelet glycoprotein IIb/IIIa inhibitor: a case report.
    Dorval JF; Soulez G; Berry C; Bonan R
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):994-7. PubMed ID: 17295326
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Splenic rupture complicating periinterventional glycoprotein IIb/IIIa antagonist therapy for myocardial infarction in polycythemia vera.
    Friedrich EB; Kindermann M; Link A; Böhm M
    Z Kardiol; 2005 Mar; 94(3):200-4. PubMed ID: 15747043
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Profound thrombocytopenia after abciximab administration in acute myocardial infarction and stent thrombosis following thrombocytopenia remission--a case report].
    Elikowski W; Rzeźniczak J; Słomczyński M; Psuja P
    Kardiol Pol; 2005 Jan; 62(1):44-7; discussion 48. PubMed ID: 15815778
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Abciximab and fatal pulmonary hemorrhage.
    Usman MH; Shah MA; ul-Islam T; Adenwalla HN; Rahman F; Baqir M; Altaf M; Venkataraman R; Cherayil M; Berger S
    Heart Lung; 2006; 35(6):423-6. PubMed ID: 17137944
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy.
    Berkowitz SD; Harrington RA; Rund MM; Tcheng JE
    Circulation; 1997 Feb; 95(4):809-13. PubMed ID: 9054735
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Severe thrombocytopenia associated with Abciximab therapy--apropos a clinical case].
    Mendes V; Resende M; Santos JM; Mourão L; Santos AL; Luís AS
    Rev Port Cardiol; 1998; 17(7-8):609-13. PubMed ID: 9741217
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acute basilar artery occlusion treated with combined intravenous Abciximab and intra-arterial tissue plasminogen activator: report of 3 cases.
    Eckert B; Koch C; Thomalla G; Roether J; Zeumer H
    Stroke; 2002 May; 33(5):1424-7. PubMed ID: 11988626
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Left ventricular wall hematoma and cardiac tamponade complicating percutaneous coronary intervention using IIb/IIIa receptor antagonists.
    Van Mieghem C; Dens J; Herregods MC; Desmet W
    J Interv Cardiol; 2003 Oct; 16(5):381-4. PubMed ID: 14603795
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Acute profound thrombocytopenia following C7E3 Fab (Abciximab) therapy: case reports, review of the literature and implications for therapy.
    Jubelirer SJ; Koenig BA; Bates MC
    Am J Hematol; 1999 Jul; 61(3):205-8. PubMed ID: 10398314
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trial.
    Savonitto S; Armstrong PW; Lincoff AM; Jia G; Sila CA; Booth J; Terrosu P; Cavallini C; White HD; Ardissino D; Califf RM; Topol EJ
    Eur Heart J; 2003 Oct; 24(20):1807-14. PubMed ID: 14563339
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The initial experience of the use of ReoPro in high-risk coronary angioplasty in Italy: the Italian Registry on the Conditions for the Use of ReoPro during Angioplasty (R.I.CO.R.D.A.)].
    Simonetti I; Gallopin M; Klugmann S; Gensini GF
    Ital Heart J Suppl; 2000 Jan; 1(1):88-96. PubMed ID: 10832124
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Alveolar hemorrhage as a complication of treatment with abciximab.
    Kalra S; Bell MR; Rihal CS
    Chest; 2001 Jul; 120(1):126-31. PubMed ID: 11451827
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Abciximab-induced alveolar hemorrhage after percutaneous coronary intervention.
    Conley M; Patino G; Romick B; Almaleh M; Campbell C; Hawkins K; Moore S; Allan P
    Can J Cardiol; 2008 Feb; 24(2):149-51. PubMed ID: 18273491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.